István Bitter

Common variants conferring risk of schizophrenia

Hreinn Stefánsson, Roel A. Ophoff, Stacy Steinberg et al. · Nature · 2009 · 1.7K citations · Full text

Life Sciences, Genetics, Molecular Genetics +12

Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression

Ella Daly, Madhukar H. Trivedi, Adam Janik et al. · JAMA Psychiatry · 2019 · 759 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Updated European Consensus Statement on diagnosis and treatment of adult ADHD

J. J. Sandra Kooij, Denise Bijlenga, Luana Salerno et al. · European Psychiatry · 2018 · 657 citations · Full text

Medicine, Psychiatry, Adult Psychiatry +13

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial

György Németh, I. Laszlovszky, Pál Czobor et al. · The Lancet · 2017 · 352 citations

Pharmacy, Pharmacotherapy, Psychiatry +14

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial

Michael J. Detke, Curtis G. Wiltse, Craig Mallinckrodt et al. · European Neuropsychopharmacology · 2004 · 283 citations

Medicine, Pharmacotherapy, Psychiatry +16